CV Sciences (CVSI) Change in Account Payables (2011 - 2013)
CV Sciences (CVSI) reported Change in Account Payables of $280538.0 for Q1 2013, up 2825.01% on a YoY basis from $9591.0 in Q1 2012, and up 1140.76% sequentially from -$26955.0 in Q4 2012.
CV Sciences (CVSI) Change in Account Payables (2011 - 2013) Analysis & Trends
CV Sciences (CVSI) has 3 years of Change in Account Payables data on file, last reported at $280538.0 in Q1 2013.
- For the quarter ending Q1 2013, Change in Account Payables rose 2825.01% year-over-year to $280538.0; the trailing twelve-month figure through Mar 2013 stood at $250724.0 (up 1287.52% YoY), and the FY2015 full-year result was $113021.0, down 40.78% from the prior year.
- Change in Account Payables advanced to $280538.0 in Q1 2013, from -$26955.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $280538.0 in Q1 2013 to a low of -$26955.0 in Q4 2012.
- A 3-year average of $31170.9 and a median of $3386.0 in 2011 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 178.46% in 2012 and soared 2825.01% in 2013, its largest moves.
- Tracing CVSI's Change in Account Payables over 3 years: stood at -$9680.0 in 2011, then sank by 178.46% to -$26955.0 in 2012, then soared by 1140.76% to $280538.0 in 2013.
- Business Quant data shows CVSI's Change in Account Payables at $280538.0 in Q1 2013, -$26955.0 in Q4 2012, and -$2411.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 280,538.00 |
| Mar 31, 2013 | 280,538.00 |
| Dec 31, 2012 | -26,955.00 |
| Dec 31, 2012 | -26,955.00 |
| Sep 30, 2012 | -2,411.00 |
| Sep 30, 2012 | -2,411.00 |
| Jun 30, 2012 | -448.00 |
| Jun 30, 2012 | -448.00 |
| Mar 31, 2012 | 9,591.00 |
| Mar 31, 2012 | 9,591.00 |
| Dec 31, 2011 | -9,680.00 |
| Dec 31, 2011 | -9,680.00 |
| Sep 30, 2011 | 14,773.00 |
| Sep 30, 2011 | 14,773.00 |
| Jun 30, 2011 | 3,386.00 |
| Jun 30, 2011 | 3,386.00 |
| Mar 31, 2011 | 11,744.00 |
| Mar 31, 2011 | 11,744.00 |